UBS analyst Anubhav Agarwal initiates coverage on Dr. Reddy's Laboratories (DRRD:IN) (NYSE: RDY) with a Sell rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE